EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine

Ali Fatehi Hassanabad, Anna N Zarzycki, Paul W M Fedak

Cardiovascular Pathology · 2024-07 · 71 · 107635

DOI: 10.1016/j.carpath.2024.107635 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Pathology, 2024-07. Verfasst von Ali Fatehi Hassanabad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiac Surgery, Department of Cardiac Science, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary…. Hauptthemen laut MEDLINE: Fibrosis, Precision Medicine, Myocardium. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 276 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Calgary Faculty of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac fibrosis is a significant contributor to heart failure, a condition that continues to affect a growing number of patients worldwide. Various cardiovascular comorbidities can exacerbate cardiac fibrosis. While fibroblasts are believed to be the primary cell type underlying fibrosis, recent and emerging data suggest that other cell types can also potentiate or expedite fibrotic processes. Over the past few decades, clinicians have developed therapeutics that can blunt the development and progression of cardiac fibrosis. While these strategies have yielded positive results, overall clinical outcomes for patients suffering from heart failure continue to be dire. Herein, we overview the molecular and cellular mechanisms underlying cardiac tissue fibrosis. To do so, we establish the known mechanisms that drive fibrosis in the heart, outline the diagnostic tools available, and summarize the treatment options used in contemporary clinical practice. Finally, we underscore the critical role the immune microenvironment plays in the pathogenesis of cardiac fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisPrecision MedicineMyocardiumHumansAnimalsHeart FailureSignal TransductionFibroblasts

Stichwörter der Autor:innen

Cardiac fibrosisHeart failureRemodelingRepairTherapeutics

Autor:innen und Institutionen

  • Section of Cardiac Surgery, Department of Cardiac Science, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Section of Cardiac Surgery, Department of Cardiac Science, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: paul.fedak@gmail.com.

Förderung

  • University of Calgary Faculty of Medicine

Zitieren

APA

Fatehi Hassanabad, A., Zarzycki, A. N., & Fedak, P. W. M. (2024). Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine. Cardiovascular Pathology, 71, 107635. https://doi.org/10.1016/j.carpath.2024.107635

Vancouver

Fatehi Hassanabad A, Zarzycki AN, Fedak PWM. Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine. Cardiovascular Pathology. 2024;71:107635. doi:10.1016/j.carpath.2024.107635

BibTeX
@article{FatehiHassanabad2024,
  author = {Fatehi Hassanabad, Ali and Zarzycki, Anna N and Fedak, Paul W M},
  title = {Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine},
  journal = {Cardiovascular Pathology},
  year = {2024},
  volume = {71},
  pages = {107635},
  doi = {10.1016/j.carpath.2024.107635}
}
Kostenlos starten →